Chemed Corp. diskutieren
Chemed Corp.
WKN: A0CBF4 / Symbol: CHE / Name: Chemed / Aktie / Anbieter & Dienstleistungen / Mid Cap /
374,00 €
0,00 %
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Royal Bank of Canada from $576.00 to $604.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Oppenheimer Holdings Inc. from $590.00 to $625.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Oppenheimer Holdings Inc. from $625.00 to $650.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Royal Bank of Canada from $604.00 to $712.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) had its price target lowered by analysts at Royal Bank of Canada from $712.00 to $697.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) had its price target lowered by analysts at Royal Bank of Canada from $697.00 to $633.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Royal Bank of Canada from $633.00 to $667.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Royal Bank of Canada from $667.00 to $674.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat
Chemed Corporation (NYSE: CHE) had its price target lowered by analysts at Bank of America Corporation from $708.00 to $650.00. They now have a "buy" rating on the stock.
Ratings data for CHE provided by MarketBeat
Chemed Corporation (NYSE: CHE) had its price target lowered by analysts at Royal Bank Of Canada from $674.00 to $640.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat
Chemed Corporation (NYSE: CHE) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $650.00 to $580.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat
Chemed Corporation (NYSE: CHE) had its price target lowered by analysts at Royal Bank Of Canada from $640.00 to $589.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat
Chemed (NYSE:CHE) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $550.00 price target on the stock, up previously from $490.00.
Ratings data for CHE provided by MarketBeat
Chemed (NYSE:CHE) had its price target lowered by analysts at Bank of America Corporation from $610.00 to $595.00. They now have a "buy" rating on the stock.
Ratings data for CHE provided by MarketBeat
Chemed (NYSE:CHE) had its price target lowered by analysts at Royal Bank Of Canada from $589.00 to $572.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat
Chemed (CHE) had its price target lowered by Oppenheimer Holdings, Inc. from $580.00 to $500.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat
Chemed (CHE) was upgraded by Wall Street Zen from "hold" to "buy".
Ratings data for CHE provided by MarketBeat
Neueste Beiträge
StockNews_com in Chemed Corp. diskutieren